Update on dyslipidemia management: Emerging CHD risk factors, new evidence and strategies--part 1 of 2

Cynthia Sanoski

Back

Update on dyslipidemia management: Emerging CHD risk factors, new evidence and strategies--part 1 of 2

Journal article

Peer reviewed

Update on dyslipidemia management: Emerging CHD risk factors, new evidence and strategies--part 1 of 2

Cynthia Sanoski

Formulary (Cleveland, Ohio), Vol.36(6), p.438

06/01/2001

View Online

Abstract

Despite a wealth of convincing evidence that demonstrates a reduction in coronary heart disease risk with the use of various lipid-lowering therapies, dyslipidemia continues to be widely undertreated in the US. By becoming familiar with treatment guidelines and with existing and emerging clinical evidence and therapeutic strategies, clinicians can improve the management of patients with dyslipidemia.

Adults

Atherosclerosis

Cardiovascular disease

Cholesterol

Clinical outcomes

Clinical trials

Disease prevention

Drug therapy

Guidelines

Health risk assessment

Heart attacks

High density lipoprotein

Homocysteine

Lipids

Low density lipoprotein

Medical disorders

Metabolic disorders

Mortality

Plasma

Risk factors

Women

Details

Title: Subtitle: Update on dyslipidemia management: Emerging CHD risk factors, new evidence and strategies--part 1 of 2
Creators: Cynthia Sanoski
Resource Type: Journal article
Publication Details: Formulary (Cleveland, Ohio), Vol.36(6), p.438
Publisher: MultiMedia Healthcare Inc
ISSN: 1082-801X
eISSN: 1938-1166
Language: English
Date published: 06/01/2001
Academic Unit: Pharmacy; Pharmacy Practice and Science
Record Identifier: 9984721230902771

Metrics

1 Record Views